abstract |
The present invention relates to 2-benzamidobenzamide derivatives as Bcl-3 inhibitors. The present invention relates to compounds of general formula (I) wherein R 1 , R 2 , R 3 , R 4 , Q, m and n are as defined above. The compounds are inhibitors of Bcl3 and are useful in the treatment of cancer, especially metastatic cancer. (I) |